Trials / Completed
CompletedNCT02169492
Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic Stroke
Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic Stroke: An Observational, Prospective and Multicenter Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 103 (estimated)
- Sponsor
- Codman & Shurtleff · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to assess the safety and effectiveness of the ReVive SE (Self- Expanding) Neurothrombectomy Device in subjects requiring mechanical thrombectomy when used according to its Instruction for use (IFU).
Conditions
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2017-05-31
- Completion
- 2017-05-31
- First posted
- 2014-06-23
- Last updated
- 2017-08-07
Locations
8 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02169492. Inclusion in this directory is not an endorsement.